| [1] |
.
[J]. Chinese Journal of Antituberculosis, 2015, 37(1): 104-106.
|
| [2] |
LEI Jian-ping.
The present status and progress in prevention and control of adverse reaction of anti-tuberculosis drugs
[J]. Chinese Journal of Antituberculosis, 2014, 36(9): 774-782.
|
| [3] |
.
[J]. Chinese Journal of Antituberculosis, 2014, 36(12): 1105-1107.
|
| [4] |
.
[J]. Chinese Journal of Antituberculosis, 2014, 36(12): 1109-1118.
|
| [5] |
.
null
[J]. Chinese Journal of Antituberculosis, 2014, 36(10): 918-919.
|
| [6] |
.
[J]. Chinese Journal of Antituberculosis, 2013, 35(12): 1036-1038.
|
| [7] |
SHI Jing-Yun, XIAO He-Ping, CHEN Gang.
null
[J]. Chinese Journal of Antituberculosis, 2010, 32(3): 179-180.
|
| [8] |
Zhong Hongjian,Liu Laxiang,Zhu Fei,Chen Wensheng,Wen Shanshi,Zhao Angui.
Further discussion on clinical value of serum tuberculosis antibody IgG in the first-treated patients with smear-positive pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2010, 32(2): 114-116.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
